Home  ›  Does Having Pneumonia Make You More Likely to Get It Again

Does Having Pneumonia Make You More Likely to Get It Again

Written By Wednesday, 11 May 2022 Add Comment Edit
  • Review
  • Open Access
  • Published:

Long-term effects of pneumonia in young children

Pneumonia volume 6,pages 101–114 (2015)Cite this article

  • 81k Accesses

  • 3 Citations

  • 11 Altmetric

  • Metrics details

Abstract

Each year an estimated 120 million episodes of pneumonia occur in children younger than 5 years of age, resulting in one 1000000 deaths globally. Inside this age group the lungs are still developing past increasing alveoli numbers and airway dimensions. Pneumonia during this critical developmental menstruum may therefore adversely touch on the lung's structure and part, with increased risk of subsequent chronic lung disease. Withal, there are few longitudinal studies of pneumonia in otherwise good for you children that extend into adulthood to aid address this important question. Nascence cohort, longitudinal, example-control and retrospective studies have reported restrictive and obstructive lung office deficits, asthma, bronchiectasis, and chronic obstructive pulmonary disease. In particular, astringent hospitalised pneumonia had the greatest chance for long-term sequelae. Most studies, however, were express past incomplete follow-upwards, some reliance upon parental retrieve, chance of diagnostic misclassification, and potential confounders such as nutrition, social impecuniousness, and pre-existing pocket-sized airways or lungs. More long-term studies measuring lung function presently after birth are needed to help uncrease the complex relationships between pneumonia and afterward chronic lung affliction, while as well addressing host responses, types of infection, and potential misreckoning variables. Meanwhile, parents of young children with pneumonia need to exist advised well-nigh the importance of symptom resolution, post-pneumonia. In addition, paying attention to factors associated with optimising lung growth such equally good diet, minimising exposure to air pollution, avoiding cigarette fume, and decreasing the gamble of preventable infections through skilful hygiene and having their children fully vaccinated should be emphasised. Finally, in the developing world and for disadvantaged communities in developed countries, public health policies leading to skilful quality housing and heating, hygiene, education, and improving socio-economical status are also essential.

1. Introduction

one.1 The burden of pneumonia

Pneumonia is the greatest crusade worldwide of childhood morbidity and mortality [ane]. The most important respiratory pathogens implicated in severe and fatal cases of childhood pneumonia are Streptococcus pneumoniae [2], Haemophilus influenzae type b [iii], respiratory syncytial virus (RSV) [iv], and seasonal influenza virus [five], three of which are already targeted by vaccines that are licensed currently. In 2010, there were an estimated 120 million episodes of clinically diagnosed pneumonia involving children younger than 5 years of age globally, including fourteen million with severe affliction requiring infirmary treatment [six]. Of greater business organization, in 2013 equally many as one one thousand thousand children died from pneumonia, accounting for 15% of all fatalities in this age group [7]. Most cases (>98%) of pneumonia and pneumonia-related deaths (>99%) are in developing countries, occurring generally out of hospital and in the starting time year of life [six]. All the same, pneumonia is too of import in developed countries, and prior to the introduction of pneumococcal conjugate vaccines at that place were an estimated 2.6 million cases of pneumonia annually in children aged younger than 5 years, including 1.5 million requiring hospitalisation, and 3,000 deaths [8]. All the same, despite high vaccine uptake, disadvantaged indigenous children living in these flush nations however have amidst the highest rates of pneumonia recorded [ix,10]. In improver to the usual recognised take a chance factors for pneumonia, such every bit household overcrowding, low birthweight and exposure to inhaled environmental toxicants, indigenous children living in remote communities as well experience early and heavy nasopharyngeal colonisation by pneumococcal serotypes not included in conjugate vaccines [11].

1.2 Clinical gaps

Despite the high prevalence of pneumonia, including its global clinical and economic importance, many gaps remain in our understanding and management of pneumonia in young children. These gaps, recently summarised in several reviews [12–14], include the long-term effects of pneumonia and its potential office in adult-focused pulmonary disorders [15]. This information is of import, for not merely managing individual patients, but too for understanding the true burden of illness, including the contribution of early on childhood pneumonia to the estimated 200 one thousand thousand people with chronic obstructive pulmonary disease (COPD) and the 235 million people with asthma worldwide [16]. Only so tin the full do good of interventions, such equally duration and type of antibiotics or the introduction of new vaccines into national immunisation programmes, be understood. In this review, we focus on the long-term (>half-dozen months) consequences of pneumonia in children and nosotros exclude studies that relate primarily to wheezing illness in children.

2. Pneumonia in immature children and subsequent adult lung affliction

Throughout the last three decades evidence has emerged suggesting that adult-onset chronic pulmonary disorders are likely to take their origins in early life. Here nosotros review the prove of the published information.

At that place are two published systematic reviews on the long-term impact of childhood pneumonia [17,18], with one review [17] too including studies relating to bronchiectasis. As the authors used different search terms, there were both similarities and differences betwixt the 2 reviews. All the same, the Thomson et al [17] review involved two boosted prospective studies [19,xx] on radiographically confirmed pneumonia.

In the studies included in the review by Edmonds et al [eighteen], a full of 722 children from thirteen studies (ten hospital, 3 community-based birth cohorts) were followed for sequelae, 61% of whom were younger than 2 years of age at the fourth dimension of their pneumonia, and none had whatsoever identifiable pre-existing hazard factors for chronic pulmonary disorders. Radiographic confirmation of pneumonia was available only for the 379 (52%) children included in the infirmary-based studies. The median length of follow-up was ten.8 (interquartile range [IQR] 2.1–17.0) years and overall at that place was a median 34% (IQR 12%–45%) attrition rate of study subjects. Lxx-seven cases (10.4%; 95% confidence interval [CI] v.iv%–xv.4%) were found to take major sequelae involving restrictive lung disease, obstructive lung disease or bronchiectasis. Meta-analysis showed the hazard of i of these complications was college in hospitalised (13.6%; 95% CI 6.2%–21.1%) than non-hospitalised children (v.5%; 95% CI 2.8%–8.3%), whilst among the pathogens, adenovirus pneumonia was associated with the highest take chances (54.8%; 95% CI 39.two%–70.five%) of developing i of these major sequelae. Of the sequelae, restrictive lung disease was the most commonly detected (v.5%; 95% CI two.5%–x.2%). Bronchiectasis, either alone (0.nine%; 95% CI 0.07%–8.7%) or in combination with restrictive lung disease (1.two%; 95% CI 0.05%–7.7%), was establish only in those who had been hospitalised for pneumonia and obstructive lung illness in those with a history of severe adenovirus pneumonia (2.8%; 95% CI 0.18%–6.4%). Nevertheless, in this review lung part tests suggesting airway obstruction were too reported in up to i-tertiary of 62 South African children ane–seven years after their pneumonia [21] and in 14 of 18 (78%) vii–8-year-old children with a history of chlamydial pneumonia in early infancy [22]. Although children younger than two years of age had a greater run a risk of sequelae than those anile 2–5 years at the time of their pneumonia, this did not reach statistical significance (13.4%; 95% CI 4.5%–22.3% vs 8.7%; 95% CI 3.one%–xiv.iii% respectively, odds ratio [OR] 1.22 [95% CI 0.21–7.1]). Furthermore, in the multivariable model only hospitalisation remained a major chance factor for sequelae (OR3.65 [95%CI one.96–6.8]).

Here, nosotros summarise studies identified from these reviews and our own search with a focus on prospective and case-command studies. Relevant studies were identified by searching the PubMed database using the terms 'children' and 'pneumonia' and 'long term', respectively in their titles or abstracts without language restrictions. Studies published prior to 13 April 2015 were included.

2.1 Prospective longitudinal and case-control studies

These information are summarised in Tables one and 2. Three large follow-up, community-based, nativity cohort studies from the United Kingdom (United kingdom of great britain and northern ireland) assessing sequelae in non-hospitalised children with clinically diagnosed pneumonia were identified. The extracted information for two nascency cohort studies was from health company records of infants born between 1920 and 1930 in Hertfordshire County, England (males merely) [23], and between 1921 and 1935 in Saint Andrews, Scotland, respectively [24]. The surviving participants from both cohorts were evaluated when they were anile in their 50s and 60s. The third community-based nativity cohort written report was from the 1958 British National Child Evolution Study where, at the age 7-yr follow-upwardly interview, parents were asked if their child ever had pneumonia [25]. Subjects in this study were assessed at 34 to 35 years of age. Each of these iii nascency cohort studies reported that pneumonia in early childhood was associated with restrictive lung role.

Table 1 Prospective birth cohort studies examining the furnishings of babyhood pneumonia upon adult lung role

Total size tabular array

Table 2 Case-control and follow-up studies examining the effects of childhood pneumonia upon adult lung function

Total size table

In contrast, two other birth cohorts [26,27] indicated pneumonia in early on childhood was associated with an obstructive rather than restrictive lung part deficit (Table ane). The first study was from Derbyshire County, England, where records for babies born between 1917 and 1922 were preserved [26]. These records also included their respiratory health, documented by health visitors in the first 2 years of life. Overall, 618 of the 1,909 (32%) men and women known to accept been born in the six called districts at that fourth dimension, now aged in their mid-60s and 70s, completed health questionnaires and underwent spirometry. After adjusting for age, pinnacle, smoking, and asthma, the 13 men with pneumonia diagnosed before age 2 years had significantly lower forced expiratory volume in one 2nd (FEV1), forced vital capacity (FVC), and FEV1/FVC values than the 315 men without a history of pneumonia. The 2nd study was from the Tucson Children's Respiratory Study, Usa of America, (USA) where 1,246 unselected healthy infants were enrolled from 1980 to 1984 and followed into adulthood [27,35]. It reported on those with a history of clinically diagnosed and radiographically confirmed pneumonia during the starting time three years of life [27]. In more than one-half of the original 66 cases, pneumonia was associated with respiratory viruses (mainly RSV) and in almost two-thirds wheezing was present. None were hospitalised. 40-four (67%) of these children were followed equally adults into their mid-to-tardily 20s and every bit a group they had persistently dumb lung function with decreased FEV1/FVC ratios and reduced mid-expiratory menses rates indicating pocket-size airway obstruction, which was only partially corrected by bronchodilators. Compared to those without pneumonia, these immature adults had a two-fold increased risk of active, physician-diagnosed asthma (OR 1.95 [95% CI one.11–3.44]).

Other birth cohort studies (Table 1) have likewise reported reduced lung office in adults following babyhood lower respiratory tract illnesses. The Newcastle Thousand Families Report, Uk, involved 1,142 infants built-in in 1947 and their lower respiratory illnesses were recorded past health visitors during the outset 5 years of life [30]. Of the 252 (22%) who were later recruited from this nativity accomplice into a nested example-control study in 1961 and underwent spirometry at age xiv-years, 122 returned for additional assessments at 49–51 years of age (Table two). Those with a history of lower respiratory illnesses earlier age 5-years had significantly lower FEV1 recordings than their good for you peers at age 14-years and they also demonstrated a greater decline in FEV1 between xiv and fifty years of age. Finally, the Barry Caerphilly Growth Written report undertaken in Barry and Caerphilly, Wales, UK, reported the results of spirometry performed on 679 of the original 951 (71%) 25-year-old subjects built-in in these ii towns between 1972 and 1974 and from whom research personnel had gathered information on upper and lower respiratory tract infections during xiv home visits from nascency until the subjects reached 5 years of historic period [28]. The major findings from this study were that lower respiratory tract infections during the first year of life were associated with decreased lung part, involving all lung function parameters except FVC, suggesting these children were at increased risk of airway obstacle. Indeed, a dose-response effect was observed and the authors estimated that a two-fold increase in lower respiratory tract infections during the first year of life was associated with a decrease in FEVi equal to that seen with cigarette smoking for ten–17 pack-years.

2.2 Retrospective studies

The review by Edmonds and colleagues [eighteen] identified seven retrospective studies published between 1971 and 2000 that reported outcomes for specific pathogens: adenovirus [36,37], Mycoplasma pneumoniae [38–40], Chlamydia trachomatis [22], and Staphylococcus aureus [41]. Withal, these data cannot be extrapolated to 'general pneumonic illnesses' because of the likely loftier option bias inherent in such retrospective studies. Moreover, none of the studies had searched systematically for other co-existing respiratory pathogens that may also have contributed to the child's clinical presentation and long-term outcomes.

Many other retrospective studies relating babyhood respiratory outcomes to poorer adult respiratory health have been published and these include population-based studies, such as that of Barker and Osmond [42], which concluded that at that place was strong evidence of a direct causal link between astute lower respiratory infection in early on childhood and chronic bronchitis in adult life. Furthermore, this study suggested that infection in early childhood had a greater influence than cigarette smoking in determining the geographical distribution of chronic bronchitis with national time trends reflecting the influence of both factors [42]. Virtually retrospective studies are consistent with the longitudinal studies' findings that early babyhood lung infections are associated with future lung illness or poorer lung function in adults [17,18,26–29].

two.three Studies focused on bronchiectasis only

The rarer complexity of bronchiectasis is characterised by chronic wet or productive cough, periodic infectious exacerbations, and irreversible bronchial dilation and wall thickening seen on either plain radiographs or computed tomography of the chest [43]. Information technology normally has multiple aetiologies, including prior severe infections, allowed deficiencies, and main ciliary dyskinesia, and its pathogenesis remains poorly understood. However, bronchiectasis in children from indigenous communities and developing countries is associated with preterm commitment and episodes of early on and recurrent pneumonia during infancy [44–47], while 30–sixty% of adults with recently diagnosed bronchiectasis report repeated lower respiratory tract infections during childhood [48–50]. It is hypothesised that severe pneumonia, including that resulting occasionally from adenovirus outbreaks, can damage ciliated airway epithelium in the growing lung, impairing airway clearance defences and setting upwards a wheel of repeated or persistent infection and inflammation involving airway infiltration by activated neutrophils and CD4+ T-lymphocytes, followed by degradation of bronchial wall supporting structures, bronchial dilatation, and ultimately bronchiectasis [51]. Nevertheless, studies that identified severe respiratory infections during babyhood equally chance factors for bronchiectasis were also retrospective and relied upon patient retrieve or involved highly specific patient groups [48–50]. Readers are referred to the review by Thomson et al [17] that included studies specifically relating to bronchiectasis post-pneumonia.

iii. Possible explanations for long-term effects

iii.1 Early lung growth and development

During normal fetal evolution and the first 3–four years of rapid mail service-natal growth, the developing lungs are well-nigh vulnerable to injury past infectious and non-infectious insults, including reprogramming by various cistron—environment interactions [52,53]. Information technology is during the early post-natal period, when new alveoli are still forming and post-natal lung growth is most rapid, that the developing lungs are most susceptible to the long-term effects of pneumonia. Lung development occurs over five phases, the start four of which are in utero, and all 5 phases tin exist influenced past maternal, genetic, and environmental factors, including infection in the critical post-natal growth and alveolarisation period [54,55]. Within the developing embryo the lung buds first appear between 4 and 7 weeks, the conducting airways are established by 17 weeks and the respiratory zone, which includes the respiratory bronchioles and alveolar ducts, is fully developed past 27-weeks gestation. Alveolar sacs outset emerge, followed by alveoli, subsequently 28 weeks and at full term 100–150 million alveoli have formed. Subsequently birth the alveoli continue to multiply reaching the estimated adult number of 300–600 million by at least 3–4 years of historic period. The alveoli also increase in volume and the airways keep growing, doubling their size past the end of adolescence in females and the mid-twenties for males [55]. During the intrauterine menses and the get-go few years of life diverse environmental insults to the developing lung may adversely impact upon future respiratory health. For case, preterm delivery tin interrupt lung development with subsequent maturation occurring out of stage compared with those born at full term, and the resulting airways are smaller with fewer alveoli and potential negative influences upon lung office [52,56].

Respiratory infections with consistent inflammatory responses may interrupt the critical alveolarisation phase of lung development, restricting alveolar numbers and/or size and leading to often mild, but dumb lung growth. The association between pneumonia and obstructive lung illness is mayhap through like mechanisms to those leading to bronchiectasis, which is an obstructive lung disease. Lung infections at the peak periods of somatic lung growth (a normal newborn has but approximately five% of a healthy adult's alveolar surface surface area [57]) may also alter the programming of lung development at a local or systemic level. The effects of early infection, especially viral lower respiratory tract infections, upon lung growth, programming and future lung function disease types are beyond the telescopic of this review and readers are referred to the respiratory literature [55,56,58].

3.2 Other confounders and effects

In improver to the effects of lower respiratory infections, maternal smoking, and other maternal factors, nutrition, and allergic sensitisation can take potential negative influences upon lung function [52,56,59,lx]. Of the above factors, solid experimental evidence on the impact of poor nutrition [61,62] and tobacco smoking in animals [63–65] support the clan studies in human literature where infants who are poorly nourished or exposed to tobacco smoke (both in utero and in early life) are more probable to have lung infections and are also independently more likely to have adult lung disease and/or poorer lung office [53,55,56]. In animal studies these effects are reversible (at least partially) since improvement in nutrition early in life results in better adult lung development [66]. Pre- and mail-natal tobacco exposure have independent long-term pulmonary effects [67,68] and cessation of tobacco exposure improves the accelerated decline in lung function [69]. While it is beyond the scope of this review to elaborate upon these factors (come across reviews [threescore,66,67]), readers should be cognisant of the importance of these problems. The potential reversibility of impaired lung growth and function too highlights the opportunities for futurity intervenions.

An alternative estimation is that, irrespective of external factors, lung function from infancy tracks throughout childhood into developed life meaning those predisposed to COPD, bronchiectasis, and other developed lung dysfunction are destined to do so, with pneumonia just being a biomarker for those with underlying abnormal lung role and growth. Consequently, information technology follows that no interventions will alter the time to come development of developed lung disease. This rather nihilistic view is, however, unduly pessimistic. Although randomised controlled trial evidence in humans is non bachelor (and likely never will be), there are many biological reasons why this opinion is incorrect. Examples include marked improvements in survival and lung office seen in patients with cystic fibrosis over the last two decades [70], the reversibility (at to the lowest degree partially) seen in beast studies described in a higher place [60,66], and the reduction in mortality from pneumonia through improved instance management [vii]. Indeed, it is highly likely that the interactions are circuitous since the host's respiratory microbiome, immune responses, epigenetic influences, and their physical environment are beingness recognised increasingly as playing a role in the human phenotypes of health and disease [71]. As shown recently for RSV in unselected term infants [72], both possibilities may non be mutually exclusive. Thus infants with smaller airways and/or reduced numbers of alveoli at birth could accept greater numbers of lower respiratory tract infections, including pneumonia, during the disquisitional post-natal menses and these infections might also pb to further disruption of alveolar multiplication and/or airway growth and development.

At this bespeak it is also worth noting that recent studies study up to twoscore% of adults with a chronic productive cough and 'difficult to control' asthma may have radiographic show of underlying bronchiectasis [73], while 29–58% of those with astringent COPD likewise have bronchiectasis as either a straight complexity of COPD or role of an overlap syndrome [74,75]. These reports highlight the complex relationships observed between early childhood respiratory infections and chronic airway disorders in adults. In that location may be at least two different processes operating in these circumstances producing either functional (COPD) and/or structural (bronchiectasis) defects. A clue to the presence of these mechanisms was provided past a recent prospective written report of respiratory exacerbations in infants with cystic fibrosis detected past a newborn screening program [76]. The overall exacerbation charge per unit in the beginning 2 years of life was negatively associated with FEV1 at v years of historic period, suggesting airway remodelling, while simply the astringent twenty% of exacerbations requiring hospitalisation were associated with structural airway injury causing bronchiectasis at historic period 5-years.

three.3 Example observation issues

An important limitation for many studies was the reliance upon parental reporting of symptoms and that some of the cases may have had bronchiolitis, virus-induced wheezing or asthma rather than pneumonia. Even when the diagnosis of pneumonia is supported by radiographic testify it can still be difficult to differentiate between patchy pulmonary infiltrates and localised atelectasis from mucous plugs in non-hospitalised children with moderate, and frequently viral, lower respiratory tract illnesses [27]. Radiographic abnormalities (including alveolar consolidation) are ofttimes present in infants with moderate-to-severe bronchiolitis [77] and many of the studies relating lower respiratory infections to long-term outcomes exercise not report on, or do not exclude, presence of wheeze in the report population. The respiratory physiology of wheeze in infants, which is more probable to occur when abnormally small airways and/or atopic sensitisation are nowadays, is probably going to exist different to that of pneumonia, which is primarily a parenchymal illness. Consequently, as these diseases have different underlying pathologies and pathogenetic mechanisms, they are as well very probable to have different long-term outcomes [59,78,79].

4. Studies strengths and weaknesses

The major strengths of the community-based birth accomplice studies are the recruitment of unselected subjects and their longitudinal nature spanning several decades, which immune prospectively collected babe and early childhood exposure data to be analysed with those describing adult respiratory outcomes [23–28,30]. Important limitations though are losses to follow-upwards, which included those who had died soon after discharge from hospital [32] and from chronic pulmonary disorders, such every bit COPD in the older aged cohorts [23,42], too as those who were also unwell to attend or to perform satisfactory lung role tests. One study assessed just men [23], while those lost to follow-up were normally socioeconomically disadvantaged and may have been at greater hazard of respiratory morbidity, even if they had never smoked [80,81]. The early nascency cohorts were also conducted before antibiotics were available. Thus the nature or likelihood of injury to the developing lung during alveolarisation may differ whether or not cases of bacterial pneumonia received antibiotics.

Despite the nativity cohort studies being prospective, the respiratory affliction information were generally nerveless by visiting healthcare workers, usually some weeks or months afterwards, and in one written report upward to 7 years afterward the event [25]. Consequently, the diagnosis of pneumonia oft relied upon parental recall and in just one of these community-based studies was the diagnosis of pneumonia fabricated by a paediatrician and confirmed radiographically [27]. Moreover, nearly studies provided petty information on the number of pneumonia episodes experienced at an private level, limiting our chapters to determine if a single episode in an infant or immature child is associated with dumb lung office in afterwards adult life or if instead pneumonia needs to be severe or recurrent to take such effects. In addition, the subjects in some studies were asked to self-report some potentially of import confounding variables, such as gestation at delivery, maternal smoking, and occupational exposures to environmental toxicants. As discussed above, an unknown proportion of these episodes may take been from bronchiolitis, virus-induced wheeze, or asthma rather than pneumonia. Thus, these studies suffered from varying degrees of potential selection, gender and recall bias, as well every bit diagnostic misclassification. Besides, as with any observational studies, the possibility of residue unmeasured confounding remains an result.

The hospital-based studies reported in the systematic review [xviii] involved small numbers of subjects (20–190), of whom 19–59% were followed for a mean of vii.8 (range 1.5–17) years. All those reporting upon a single respiratory pathogen (S. aureus, G. pneumoniae and C. trachomatis) were retrospective. Each study was limited by incomplete data drove, failure to utilize sensitive diagnostic techniques to exclude co-infection by other respiratory pathogens, likely referral bias, and differential patient follow-upwardly where the potential existed for children with symptoms to be more likely to be brought back for review. Finally, other major limitations were the lack of baseline clinical and lung function information prior to the episode of pneumonia in all but one study [27] and the lack of data on potential confounders and the effect of interventions provided.

v. Conclusions and futurity directions

Information technology is widely recognised that pneumonia in young children causes a considerable worldwide burden of mortality and short-term morbidity in survivors. What is less well known is that infectious insults to the rapidly growing and still developing lungs in the first 1–three years of life are independently associated with an increased risk of impaired lung function in adulthood. The risks announced greatest for those whose affliction is of sufficient severity to warrant treatment in infirmary. The long-term effects associated with early on childhood pneumonia include restrictive or obstructive lung function deficits and an increased chance of adult asthma, non-smoking related COPD, and bronchiectasis. The studies underpinning these observations do however take important limitations. They are a mixture of prospective and retrospective studies, involving both community- and hospital-based populations experiencing illness of varying severity, with incomplete follow-up and opportunities for sampling and remember bias, and diagnostic misclassification of bronchitis, bronchiolitis, viral-induced wheezing and asthma equally pneumonia. About important of all is that most studies do not take prior lung function data for their pneumonia cases and subsequent impairments in lung function might just reflect pre-existing abnormalities in already susceptible infants and immature children.

More than loftier-quality, long-term studies are needed, ideally involving nascence cohorts from both developing and adult countries with antenatal recruitment and, whenever feasible, measurements of lung office should be conducted shortly after nascence. To minimise the risk of misclassification, standardised diagnostic criteria for pneumonia should likewise exist used. Such studies are challenging and expensive to perform, simply can help focus hereafter research, while helping to guide clinical practice and kid public health policies. A promising get-go has been made in Due south Africa with the Drakenstein Child Health Report [82]. Although, by relying solely upon the World Wellness Organization clinical definitions of pneumonia many of the cases volition have lower airway, rather than alveolar involvement, and thus several of the questions raised in this review will not be addressed by this birth accomplice study. The underlying airway cellular, immunological, and microbiological mechanisms associated with chronic pulmonary disorders originating in the antenatal and early childhood periods are besides important, only beyond the telescopic of this review and are discussed elsewhere [54–59,83]. All the same, gaining an agreement of these mechanisms is vital for developing effective therapeutic interventions to either foreclose or opposite lifelong injury to the developing lungs. Meanwhile, for clinicians information technology is important to recognise that immature children with pneumonia are at run a risk of chronic pulmonary disease equally adults, irrespective whether this is a direct result of their infection or that susceptibility to pneumonia itself is a marking for potential underlying deficits in lung office. Either way, a conscientious history should be taken for each patient, recording details of the pregnancy, nature and timing of the birth, maternal and household tobacco smoking history, exposure to indoor (e.yard. biomass fuels) and outdoor air pollution, prior history of respiratory symptoms, especially chronic cough, wheezing or breathing difficulties, previous respiratory illness episodes, their nutritional state, immunisation tape and personal and family unit histories of atopy, asthma or other chronic lung diseases. The parents and caregivers should be counselled about the possibility of adult-onset lung disease in the child and advised accordingly of the importance of avoiding active and passive smoking, indoor and outdoor air pollution, hereafter occupational inhalant exposures, and ensuring that all recommended vaccines are received in a timely manner. Public wellness interventions, such as advisable housing, household heating and hygiene, reducing barriers to accessing healthcare and immunisation services, promoting didactics, and improving socio-economic status are also important [29,84], especially in developing countries and the economically disadvantaged in adult countries (e.g. indigenous populations in Australia, New Zealand, Canada, and the USA with loftier burdens of lung disease [85]).

Finally, it is essential that the complex relationships between pre-existing lung damage, early childhood pneumonia, and chronic pulmonary disorders in adults are disentangled and amend understood and then that policy makers tin brand informed decisions about public health interventions to help stem the tide of chronic lung disease in adults. As an example, it volition be necessary to take into account that vaccines confronting common respiratory pathogens may take longer-term benefits than simply protecting against episodes of astute pneumonia. By 2030, COPD is predicted to become the third leading cause of deaths globally [86], and with almost one-half of the cases now occurring in adults who take never smoked, the roles played by exposure to other inhaled ecology toxicants and lower respiratory tract infections during early babyhood need to exist highlighted, investigated, and managed at both an individual and population level [87].

References

  1. Nair H, Simões EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JS et al.; Severe Astute Lower Respiratory Infections Working Group. Global and regional burden of hospital admissions for severe astute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013;381:1380–ninety. https://doi.org/www.dx.doi.org/10.1016/S0140-6736(12)61901-ane. PMID:23369797

    PubMed  PubMed Key  Google Scholar

  2. O'Brien KL, Wolfson LJ, Watt JP, Henkle East, Deloria-Knoll Chiliad, McCall N et al.; Hib and Pneumococcal Global Brunt of Disease Written report Team. Burden of illness acquired by Streptococcus pneumoniae in children younger than five years: global estimates. Lancet 2009;374:893–902. https://doi.org/www.dx.doi.org/10.1016/S0140-6736(09)61204-vi. PMID:19748398

    PubMed  Google Scholar

  3. Watt JP, Wolfson LJ, O'Brien KL, Henkle Due east, Deloria-Knoll M, McCall Due north et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of illness caused by Haemophilus influenzae blazon b in children younger than 5 years: global estimates. Lancet 2009;374:903–11. https://doi.org/www.dx.doi.org/10.1016/S0140-6736(09)61203-iv. PMID:19748399

    PubMed  Google Scholar

  4. Nair H, Nokes DJ, Gessner BD, Dherani G, Madhi SA, Singleton RJ et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–55. https://doi.org/www.dx.doi.org/ten.1016/S0140-6736(10)60206-i. PMID:20399493

    PubMed  PubMed Primal  Google Scholar

  5. Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011;378:1917–thirty. https://doi.org/www.dx.doi.org/ten.1016/S0140-6736(11)61051-ix. PMID:22078723

    PubMed  Google Scholar

  6. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381:1405–16. https://doi.org/www.dx.doi.org/10.1016/S0140-6736(13)60222-6. PMID:23582727

    PubMed  Google Scholar

  7. Liu 50, Oza S, Hogan D, Perin J, Rudan I, Lawn JE et al. Global, regional, and national causes of kid mortality in 2000–thirteen, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015;385:430–forty. https://doi.org/www.dx.doi.org/x.1016/S0140-6736(14)61698-vi. PMID:25280870

    PubMed  Google Scholar

  8. Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ishiwada N et al. The brunt of childhood pneumonia in the adult world: a review of the literature. Pediatr Infect Dis J 2013;32:e119–27. PMID:23099423

    Google Scholar

  9. O'Grady KA, Taylor-Thomson DM, Chang AB, Torzillo PJ, Morris PS, Mackenzie GA et al. Rates of radiologically confirmed pneumonia as defined by the World Health Organization in Northern Territory Indigenous children. Med J Aust 2010;192:592–5. PMID:20477736

    PubMed  Google Scholar

  10. Kovesi T. Respiratory affliction in Canadian First Nations and Inuit children. Paediatr Child Health (Oxford) 2012;17:376–eighty. PMID:23904781

    Google Scholar

  11. O'Grady KA, Lee KJ, Carlin JB, Torzillo PJ, Chang AB, Mulholland EK et al. Increased take chances of hospitalization for acute lower respiratory tract infection amongst Australian indigenous infants v–23 months of age following pneumococcal vaccination: a accomplice written report. Clin Infect Dis 2010;50:970–8. PMID:20192729 https://doi.org/www.dx.doi.org/10.1086/651079

    PubMed  Google Scholar

  12. Chang AB, Ooi MH, Perera D, Grimwood Grand. Improving the Diagnosis, Management, and Outcomes of Children with Pneumonia: Where are the Gaps? Front Pediatr 2013;ane:29. https://doi.org/www.dx.doi.org/10.3389/fped.2013.00029. PMID:24400275

    PubMed  PubMed Central  Google Scholar

  13. Prayle A, Atkinson K, Smyth A. Pneumonia in the developed world. Paediatr Respir Rev 2011;12:60–nine. https://doi.org/www.dx.doi.org/10.1016/j.prrv.2010.09.012. PMID:21172677

    PubMed  Google Scholar

  14. Lassi ZS, Das JK, Haider SW, Salam RA, Qazi SA, Bhutta ZA. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of historic period. Curvation Dis Kid 2014;99:687–93. https://doi.org/world wide web.dx.doi.org/10.1136/archdischild-2013-304023. PMID:24431417

    PubMed  Google Scholar

  15. Henderson AJ. The child is male parent of the man: the importance of early life influences on lung development. Thorax 2014;69:976–7. https://doi.org/www.dx.doi.org/10.1136/thoraxjnl-2014-205752. PMID:25052576

    PubMed  Google Scholar

  16. Ferkol T, Schraufnagel D. The global brunt of respiratory disease. Ann Am Thorac Soc 2014;11:404–6. https://doi.org/www.dx.doi.org/10.1513/AnnalsATS.201311-405PS. PMID:24673696

    PubMed  Google Scholar

  17. Thomson 1000, Myer L, Zar HJ. The impact of pneumonia on development of chronic respiratory disease in childhood. Pediatr Allergy Immunol Pulmonol. 2010;23:279–90. https://doi.org/www.dx.doi.org/10.1089/ped.2010.0056

    Google Scholar

  18. Edmond K, Scott Due south, Korczak V, Ward C, Sanderson C, Theodoratou E et al. Long term sequelae from babyhood pneumonia; systematic review and meta-assay. PLoS ONE 2012;seven:e31239. https://doi.org/world wide web.dx.doi.org/10.1371/journal.pone.0031239. PMID:22384005

    Google Scholar

  19. Eastham KM, Hammal DM, Parker L, Spencer DA. A follow-up report of children hospitalised with community-caused pneumonia. Arch Dis Kid 2008;93:755–9. https://doi.org/www.dx.doi.org/ten.1136/adc.2007.128900. PMID:18381341

    CAS  PubMed  Google Scholar

  20. Kycler Z, Breborowicz A, Olejniczak Yard, Alkiewicz J, Bugaj U. Respiratory problems in children after severe pneumonia. Pneumonol Alergol Pol 2001;69:167–73. PMID:11575000

    CAS  PubMed  Google Scholar

  21. Wesley AG. Prolonged later-furnishings of pneumonia in children. S Afr Med J 1991;79:73–6. PMID:1989091

    CAS  PubMed  Google Scholar

  22. Weiss SG, Newcomb RW, Beem MO. Pulmonary cess of children after chlamydial pneumonia of infancy. J Pediatr 1986;108:659–64. https://doi.org/www.dx.doi.org/x.1016/S0022-3476(86)81037-10. PMID:3701509

    CAS  PubMed  Google Scholar

  23. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to developed lung function and decease from chronic obstructive airways disease. BMJ 1991;303:671–five. https://doi.org/www.dx.doi.org/10.1136/bmj.303.6804.671. PMID:1912913

    CAS  PubMed  PubMed Central  Google Scholar

  24. Shaheen SO, Sterne JA, Tucker JS, Florey CD. Birth weight, babyhood lower respiratory tract infection, and adult lung function. Thorax 1998;53:549–53. https://doi.org/www.dx.doi.org/10.1136/thx.53.vii.549. PMID:9797752

    CAS  PubMed  PubMed Key  Google Scholar

  25. Johnston ID, Strachan DP, Anderson Hour. Effect of pneumonia and whooping cough in childhood on adult lung function. North Engl J Med 1998;338:581–vii. https://doi.org/www.dx.doi.org/x.1056/NEJM199802263380904. PMID:9475765

    CAS  PubMed  Google Scholar

  26. Shaheen And so, Barker DJ, Shiell AW, Crocker FJ, Wield GA, Holgate ST. The relationship betwixt pneumonia in early on childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 1994;149:616–9. https://doi.org/www.dx.doi.org/x.1164/ajrccm.149.3.8118627. PMID:8118627

    CAS  PubMed  Google Scholar

  27. Chan JY, Stern DA, Guerra South, Wright AL, Morgan WJ, Martinez FD. Pneumonia in childhood and impaired lung office in adults: a longitudinal study. Pediatrics 2015;135:607–sixteen. https://doi.org/world wide web.dx.doi.org/x.1542/peds.2014-3060. PMID:25733757

    PubMed  PubMed Fundamental  Google Scholar

  28. Lopez Bernal JA, Upton MN, Henderson AJ, Dedman D, McCarthy A, Davey Smith G et al. Lower respiratory tract infection in the starting time twelvemonth of life is associated with worse lung function in adult life: prospective results from the Barry Caerphilly Growth study. Ann Epidemiol 2013;23:422–7. https://doi.org/world wide web.dx.doi.org/x.1016/j.annepidem.2013.05.006. PMID:23790346

    PubMed  Google Scholar

  29. Colley JR, Douglas JW, Reid DD. Respiratory disease in young adults: influence of early childhood lower respiratory tract illness, social grade, air pollution, and smoking. BMJ 1973;3:195–8. https://doi.org/www.dx.doi.org/10.1136/bmj.3.5873.195. PMID:4718835

    CAS  PubMed  Google Scholar

  30. Tennant Pw, Gibson GJ, Parker L, Pearce MS. Childhood respiratory illness and lung function at ages 14 and l years: babyhood respiratory disease and lung part. Chest 2010;137:146–55. https://doi.org/www.dx.doi.org/x.1378/chest.09-0352. PMID:19581355

    PubMed  Google Scholar

  31. Mok JY, Simpson H. Effect for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child 1984;59:306–9. https://doi.org/world wide web.dx.doi.org/ten.1136/adc.59.iv.306. PMID:6721555

    CAS  PubMed  PubMed Central  Google Scholar

  32. Puchalski Ritchie LM, Howie SR, Arenovich T, Cheung YB, Weber One thousand, Moore S et al. Long-term morbidity from astringent pneumonia in early on childhood in The Gambia, West Africa: a follow-up study. Int J Tuberc Lung Dis 2009;thirteen:527–32. PMID:19335961

    CAS  PubMed  Google Scholar

  33. Piippo-Savolainen Eastward, Remes Due south, Kannisto S, Korhonen Thou, Korppi M. Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up written report. Arch Pediatr Adolesc Med 2004;158:1070–vi. https://doi.org/www.dx.doi.org/10.1001/archpedi.158.11.1070. PMID:15520345

    PubMed  Google Scholar

  34. Chang AB, Masel JP, Boyce NC, Torzillo PJ. Respiratory morbidity in primal Australian Aboriginal children with alveolar lobar abnormalities. Med J Aust 2003;178:490–4. PMID:12741934

    PubMed  Google Scholar

  35. Castro-Rodríguez JA, Holberg CJ, Wright AL, Halonen 1000, Taussig LM, Morgan WJ et al. Clan of radiologically ascertained pneumonia before age 3 year with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Intendance Med 1999;159:1891–7. https://doi.org/www.dx.doi.org/10.1164/ajrccm.159.6.9811035. PMID:10351936

    PubMed  Google Scholar

  36. Similä S, Linna O, Lanning P, Heikkinen Eastward, Ala-Houhala M. Chronic lung damage caused by adenovirus blazon 7: a 10-year follow-up study. Breast 1981;lxxx:127–31. https://doi.org/world wide web.dx.doi.org/10.1378/breast.80.2.127. PMID:6265156

    PubMed  Google Scholar

  37. Sly PD, Soto-Quiros ME, Landau LI, Hudson I, Newton-John H. Factors predisposing to abnormal pulmonary role subsequently adenovirus blazon 7 pneumonia. Arch Dis Child 1984;59:935–9. https://doi.org/www.dx.doi.org/x.1136/adc.59.10.935. PMID:6093715

    CAS  PubMed  PubMed Central  Google Scholar

  38. Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 1984;59:1034–7. https://doi.org/world wide web.dx.doi.org/10.1136/adc.59.eleven.1034. PMID:6508338

    CAS  PubMed  PubMed Central  Google Scholar

  39. Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography afterward Mycoplasma pneumonia. Pediatrics 2000;105:372–eight. https://doi.org/world wide web.dx.doi.org/10.1542/peds.105.2.372. PMID:10654958

    CAS  PubMed  Google Scholar

  40. Mok JY, Inglis JM, Simpson H. Mycoplasma pneumoniae infection. A retrospective review of 103 hospitalised children. Acta Paediatr Scand 1979;68:833–nine. https://doi.org/www.dx.doi.org/ten.1111/j.1651-2227.1979.tb08220.x. PMID:539406

    CAS  PubMed  Google Scholar

  41. Ceruti E, Contreras J, Neira G. Staphylococcal pneumonia in childhood. Long-term follow-up including pulmonary function studies. Am J Dis Kid 1971;122:386–92. https://doi.org/www.dx.doi.org/10.1001/archpedi.1971.02110050056004. PMID:5129527

    CAS  PubMed  Google Scholar

  42. Barker DJ, Osmond C. Childhood respiratory infection and developed chronic bronchitis in England and Wales. Br Med J (Clin Res Ed) 1986;293:12715. PMID:3096461 https://doi.org/world wide web.dx.doi.org/10.1136/bmj.293.6557.1271

    CAS  PubMed  Google Scholar

  43. Chang AB, Bong SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA et al.; extended voting group. Chronic suppurative lung illness and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Commonwealth of australia and New Zealand guidelines. Med J Aust 2015;202:21–3. https://doi.org/www.dx.doi.org/10.5694/mjac14.00287. PMID:25588439

    Google Scholar

  44. Singleton R, Morris A, Redding Yard, Poll J, Holck P, Martinez P et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 2000;29:182–seven. PMID:10686038

    CAS  PubMed  Google Scholar

  45. Valery PC, Torzillo PJ, Mulholland Thou, Boyce NC, Purdie DM, Chang AB. Hospital-based case-command written report of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 2004;23:902–8. https://doi.org/www.dx.doi.org/10.1097/01.inf.0000142508.33623.2f. PMID:15602188

    PubMed  Google Scholar

  46. Singleton RJ, Valery PC, Morris P, Byrnes CA, Grimwood K, Redding M et al. Indigenous children from iii countries with non-cystic fibrosis chronic suppurative lung affliction/bronchiectasis. Pediatr Pulmonol 2014;49:189–200. https://doi.org/www.dx.doi.org/x.1002/ppul.22763. PMID:23401398

    PubMed  Google Scholar

  47. Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr 2014;14:iv. https://doi.org/www.dx.doi.org/ten.1186/s12887-014-0299-y. PMID:25492164

    PubMed  PubMed Central  Google Scholar

  48. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1277–84. https://doi.org/world wide web.dx.doi.org/10.1164/ajrccm.162.iv.9906120. PMID:11029331

    CAS  PubMed  Google Scholar

  49. King PT, Holdsworth SR, Farmer M, Freezer Due north, Villanueva E, Holmes PW. Phenotypes of adult bronchiectasis: onset of productive coughing in babyhood and adulthood. COPD 2009;6:130–6. https://doi.org/world wide web.dx.doi.org/x.1080/15412550902766934. PMID:19378226

    PubMed  Google Scholar

  50. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007;101:1163–70. https://doi.org/www.dx.doi.org/10.1016/j.rmed.2006.11.008. PMID:17223027

    CAS  PubMed  Google Scholar

  51. Dagli E. Non cystic fibrosis bronchiectasis. Paediatr Respir Rev 2000;1:64–70. https://doi.org/www.dx.doi.org/x.1053/prrv.2000.0011. PMID:16263448

    CAS  PubMed  Google Scholar

  52. Svanes C, Sunyer J, Plana Due east, Dharmage Southward, Heinrich J, Jarvis D et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65:fourteen–20. https://doi.org/www.dx.doi.org/x.1136/thx.2008.112136. PMID:19729360

    CAS  PubMed  Google Scholar

  53. Britt RD Jr, Faksh A, Vogel E, Martin RJ, Pabelick CM, Prakash YS. Perinatal factors in neonatal and pediatric lung diseases. Expert Rev Respir Med 2013;7:515–31. https://doi.org/www.dx.doi.org/10.1586/17476348.2013.838020. PMID:24090092

    CAS  PubMed  PubMed Central  Google Scholar

  54. Smith LJ, McKay KO, van Asperen PP, Selvadurai H, Fitzgerald DA. Normal development of the lung and premature nascence. Paediatr Respir Rev 2010;11:135–42. https://doi.org/www.dx.doi.org/10.1016/j.prrv.2009.12.006. PMID:20692626

    PubMed  Google Scholar

  55. Stocks J, Hislop A, Sonnappa Due south. Early lung development: lifelong outcome on respiratory health and disease. Lancet Respir Med 2013;1:728–42. https://doi.org/www.dx.doi.org/10.1016/S2213-2600(xiii)70118-viii. PMID:24429276

    PubMed  Google Scholar

  56. Carraro Due south, Scheltema N, Bont Fifty, Baraldi E. Early on-life origins of chronic respiratory diseases: agreement and promoting good for you ageing. Eur Respir J 2014;44:1682–96. https://doi.org/world wide web.dx.doi.org/ten.1183/09031936.00084114. PMID:25323240

    PubMed  Google Scholar

  57. Hislop AA, Wigglesworth JS, Desai R. Alveolar development in the human fetus and infant. Early Hum Dev 1986;13:1–xi. https://doi.org/www.dx.doi.org/x.1016/0378-3782(86)90092-seven. PMID:3956418

    CAS  PubMed  Google Scholar

  58. Fuchs O, von Mutius E. Prenatal and childhood infections: implications for the development and treatment of childhood asthma. Lancet Respir Med 2013;one:743–54. https://doi.org/world wide web.dx.doi.org/10.1016/S2213-2600(13)70145-0. PMID:24429277

    PubMed  Google Scholar

  59. Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective office in inception and persistence of wheezing. Eur Respir J 2015;45:774–89. https://doi.org/world wide web.dx.doi.org/ten.1183/09031936.00062714. PMID:25359340

    CAS  PubMed  Google Scholar

  60. Sahebjami H. Nutrition and lung structure and function. Exp Lung Res 1993;19:105–24. https://doi.org/world wide web.dx.doi.org/x.3109/01902149309031714. PMID:8467757

    CAS  PubMed  Google Scholar

  61. Sahebjami H, MacGee J. Effects of starvation on lung mechanics and biochemistry in immature and old rats. J Appl Physiol (1985) 1985;58:778–84. PMID:3156843

    CAS  PubMed  Google Scholar

  62. Maritz Chiliad, Probyn Grand, De Matteo R, Snibson K, Harding R. Lung parenchyma at maturity is influenced past postnatal growth but not by moderate preterm nativity in sheep. Neonatology 2008;93:28–35. https://doi.org/www.dx.doi.org/10.1159/000105522. PMID:17630495

    PubMed  Google Scholar

  63. Collins MH, Moessinger AC, Kleinerman J, Bassi J, Rosso P, Collins AM et al. Fetal lung hypoplasia associated with maternal smoking: a morphometric analysis. Pediatr Res 1985;19:408–12. https://doi.org/www.dx.doi.org/ten.1203/00006450-198519040-00018. PMID:4000765

    CAS  PubMed  Google Scholar

  64. Maritz GS, Morley CJ, Harding R. Early developmental origins of impaired lung construction and role. Early Hum Dev 2005;81:763–71. https://doi.org/www.dx.doi.org/ten.1016/j.earlhumdev.2005.07.002. PMID:16081227

    PubMed  Google Scholar

  65. Blacquière MJ, Timens W, Melgert BN, Geerlings M, Postma DS, Hylkema MN. Maternal smoking during pregnancy induces airway remodelling in mice offspring. Eur Respir J 2009;33:1133–40. https://doi.org/world wide web.dx.doi.org/x.1183/09031936.00129608. PMID:19129273

    PubMed  Google Scholar

  66. Shaheen Due south, Barker DJ. Early lung growth and chronic airflow obstruction. Thorax 1994;49:533–6. https://doi.org/world wide web.dx.doi.org/10.1136/thx.49.six.533. PMID:8016787

    CAS  PubMed  PubMed Fundamental  Google Scholar

  67. U.S. Department of Health and Homo Services. The health consequences of involuntary exposure to tobacco fume: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Command and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Affliction Prevention and Wellness Promotion, Office on Smoking and Health, 2006

    Google Scholar

  68. DiFranza JR, Aligne CA, Weitzman Thou. Prenatal and postnatal environmental tobacco smoke exposure and children'due south health. Pediatrics 2004;113 Suppl:1007–xv. PMID:15060193

    PubMed  Google Scholar

  69. Willemse BW, Postma DS, Timens Westward, ten Hacken NH. The affect of smoking abeyance on respiratory symptoms, lung office, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464–76. https://doi.org/www.dx.doi.org/x.1183/09031936.04.00012704. PMID:15065840

    CAS  PubMed  Google Scholar

  70. Stephenson AL, Tom M, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA et al. A gimmicky survival analysis of individuals with cystic fibrosis: a cohort study. Eur Respir J 2015;45:670–9. https://doi.org/www.dx.doi.org/10.1183/09031936.00119714. PMID:25395034

    PubMed  Google Scholar

  71. Holt PG. The mechanism or mechanisms driving atopic asthma initiation: The babe respiratory microbiome moves to center stage. J Allergy Clin Immunol 2015;136:15–22. PMID:26145983 https://doi.org/www.dx.doi.org/10.1016/j.jaci.2015.05.011

    PubMed  Google Scholar

  72. Zomer-Kooijker Yard, Uiterwaal CS, van der Gugten AC, Wilbrink B, Bont LJ, van der Ent CK. Decreased lung part precedes astringent respiratory syncytial virus infection and postal service-respiratory syncytial virus wheeze in term infants. Eur Respir J 2014;44:666–74. https://doi.org/www.dx.doi.org/10.1183/09031936.00009314. PMID:24993909

    PubMed  Google Scholar

  73. Gupta Southward, Siddiqui S, Haldar P, Raj JV, Entwisle JJ, Wardlaw AJ et al. Qualitative assay of high-resolution CT scans in severe asthma. Breast 2009;136:1521–8. https://doi.org/world wide web.dx.doi.org/10.1378/chest.09-0174. PMID:19542254

    PubMed  PubMed Central  Google Scholar

  74. O'Donnell AE. Bronchiectasis in patients with COPD: a distinct COPD phenotype? Chest 2011;140:1107–8. https://doi.org/www.dx.doi.org/10.1378/breast.xi-1484. PMID:22045871

    PubMed  Google Scholar

  75. Hurst JR, Elborn JS, De Soyza A; BRONCH-Britain Consortium. COPD-bronchiectasis overlap syndrome. Eur Respir J 2015;45:310–3. https://doi.org/www.dx.doi.org/10.1183/09031936.00170014. PMID:25653262

    PubMed  Google Scholar

  76. Byrnes CA, Vidmar S, Cheney JL, Carlin JB, Armstrong DS, Cooper PJ et al.; ACFBAL Study Investigators. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of historic period. Thorax 2013;68:643–51. https://doi.org/www.dx.doi.org/10.1136/thoraxjnl-2012-202342. PMID:23345574

    PubMed  PubMed Fundamental  Google Scholar

  77. Carsin A, Gorincour Chiliad, Bresson V, Oudyi Thousand, David M, Mancini J et al. Breast radiographs in infants hospitalized for astute bronchiolitis: real data or just irradiation?. Arch Pediatr 2012;xix:1308–15. https://doi.org/www.dx.doi.org/10.1016/j.arcped.2012.09.019. PMID:23141565

    CAS  PubMed  Google Scholar

  78. Tai A, Tran H, Roberts 1000, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014;69:805–10. https://doi.org/www.dx.doi.org/10.1136/thoraxjnl-2013-204815. PMID:24646659

    PubMed  Google Scholar

  79. Kusel MM, Kebadze T, Johnston SL, Holt PG, Sly PD. Delirious respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J 2012;39:876–82. https://doi.org/world wide web.dx.doi.org/10.1183/09031936.00193310. PMID:21920891

    CAS  PubMed  Google Scholar

  80. Ore T, Ireland P. Chronic obstructive pulmonary disease hospitalisations and mortality in Victoria: assay of variations by socioeconomic status [Epub alee of print]. Aust N Z J Public Health 2015

    Google Scholar

  81. Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease amongst never-smokers in Korea. Int J Chron Obstruct Pulmon Dis 2015;10:497–506. https://doi.org/world wide web.dx.doi.org/10.2147/COPD.S77662. PMID:25784796

    PubMed  PubMed Key  Google Scholar

  82. le Roux DM, Myer L, Nicol MP, Zar HJ. Incidence and severity of childhood pneumonia in the first year of life in a Southward African nascence cohort: the Drakenstein Kid Health Study. Lancet Glob Wellness 2015;3:e95–103. https://doi.org/www.dx.doi.org/x.1016/S2214-109X(fourteen)70360-two. PMID:25617203

    PubMed  Google Scholar

  83. Feldman As, He Y, Moore ML, Hershenson MB, Hartert TV. Toward principal prevention of asthma. Reviewing the prove for early-life respiratory viral infections equally modifiable risk factors to preclude babyhood asthma. Am J Respir Crit Intendance Med 2015;191:34–44. https://doi.org/world wide web.dx.doi.org/ten.1164/rccm.201405-0901PP. PMID:25369458

    PubMed  PubMed Central  Google Scholar

  84. Zar HJ, Ferkol TW. The global brunt of respiratory disease-impact on child wellness. Pediatr Pulmonol 2014;49:430–4. https://doi.org/world wide web.dx.doi.org/10.1002/ppul.23030. PMID:24610581

    PubMed  Google Scholar

  85. Chang AB, Marsh RL, Upham JW, Hoffman LR, Smith-Vaughan H, Holt D et al. Toward making inroads in reducing the disparity of lung wellness in Australian Indigenous and New Zealand Maori children. Forepart Pediatr 2015;3:ix. https://doi.org/www.dx.doi.org/10.3389/fped.2015.00009. PMID:25741502

    PubMed  PubMed Fundamental  Google Scholar

  86. World Health Organization. Chronic respiratory diseases. Burden of COPD. https://doi.org/www.who.int/respiratory/copd/burden/en; accessed 24th April, 2015.

    Google Scholar

  87. Salvi SS, Barnes PJ. Chronic obstructive pulmonary illness in non-smokers. Lancet 2009;374:733–43. https://doi.org/world wide web.dx.doi.org/x.1016/S0140-6736(09)61303-nine. PMID:19716966

    PubMed  Google Scholar

Download references

Funding: AC is funded past an Australian National Health and Medical Inquiry Council (NHMRC) practitioner fellowship (Grant 1058213). KG and AC are funded by a NHMRC Centre of Enquiry Excellence grant (1040830) on lung health in Indigenous children. The funders had no role in study design, collection and analysis of data, decision to publish, or writing of the manuscript.

Competing interests: KG has been a member of informational boards on pneumonia, otitis media, and pneumococcal cohabit vaccines for GlaxoSmithKline (GSK) Biologicals. Ac has received an investigator-driven grant from GSK evaluating the impact of a vaccine on the lower airways of children.

Provenance and peer review: Commissioned; externally peer reviewed.

Author information

Affiliations

  1. Menzies Health Constitute Queensland, Griffith Academy, Gold Coast, Queensland, Building G40, Gold Coast campus, 4222, Australia

    Keith Grimwood

  2. Department of Infectious Disease and Immunology, and Department of Paediatrics, Gold Coast Health, Gold Coast, Queensland, Australia

    Keith Grimwood

  3. Queensland Children's Medical Research Institute, Queensland Academy of Technology, Brisbane, Queensland, Australia

    Anne B. Chang

  4. Menzies School of Health Inquiry, Charles Darwin University, Darwin, Northern Territory, Australia

    Anne B. Chang

  5. Section of Respiratory and Sleep Medicine, Lady Cilento Hospital, Brisbane, Queensland, Australia

    Anne B. Chang

Respective author

Correspondence to Keith Grimwood.

Additional data

Author contributions: All authors met ICMJE authorship criteria. KG, AC generated and designed the inquiry plan. KG, Air conditioning contributed equally to the writing of the commencement draft of the manuscript and writing of the manuscript. KG, AC hold with the manuscript results and conclusions. KG, AC canonical the final version of the manuscript. Citation: Grimwood 1000 and Chang AB. Long-term effects of pneumonia in young children. pneumonia 2015;six:101–114

Rights and permissions

Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Grimwood, K., Chang, A.B. Long-term effects of pneumonia in immature children. Pneumonia vi, 101–114 (2015). https://doi.org/10.15172/pneu.2015.half dozen/671

Download citation

  • Received:

  • Accepted:

  • Published:

  • Effect Date:

  • DOI : https://doi.org/ten.15172/pneu.2015.6/671

Keywords

  • asthma
  • bronchiectasis
  • child
  • chronic obstructive pulmonary disease
  • pneumonia

reavesminat1977.blogspot.com

Source: https://pneumonia.biomedcentral.com/articles/10.15172/pneu.2015.6/671

0 Response to "Does Having Pneumonia Make You More Likely to Get It Again"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel